Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.52 -0.24 (-3.09%) Market Cap: 998.89 Mil Enterprise Value: 999.89 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 80/100

Maravai LifeSciences Holdings Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 23, 2022 / 07:00PM GMT
Release Date Price: $37.74 (-2.83%)
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

It's Paul Knight, analyst at KeyBanc on the life science industry. With us today is Brian Neel, Chief Operating Officer of Maravai. We appreciate your time today, Brian. And I thought if we could just start with going over your background and what you're doing at Maravai.

Brian Neel
Maravai LifeSciences Holdings, Inc. - COO of Nucleic Acid Production

Yes. Absolutely. Maravai LifeSciences is actually a business that has several brands within it. One of those brands I think we're going to focus on today is TriLink BioTechnologies. And at TriLink, we specialize really in 2 key areas. We have a technology that we've invested quite heavily in the last few years, a CleanCap technology, which is a capping reagent we use for mRNA production. We also have other products that we sell along with the CleanCap as a stand-alone product.

The second part of our business is a CDMO business that's very focused on mRNA API development production, specifically right now for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot